The finding of TREM2 as a critical regulator of macrophage-mediated fibrosis makes it a promising therapeutic target for intervention for lung fibrotic disease.

Three UAB professors offer expertise on springtime allergies and ways to mitigate pollen’s grip.

UAB is combating youth tobacco use with its ninth annual award from the Alabama Department of Public Health.

Funded by the National Institutes of Health, HEALTHe Birmingham will measure the effects of community revitalization on residents’ health.

By showing a critical role for sialylation in the biophysical properties of mucus and mucus transport, the study identifies a possible therapeutic target for the treatment of cystic fibrosis and other muco-obstructive diseases.

Linda Morgan’s transplant journey has inspired many and will continue to do so as she shares her story with the world.

This live biotherapeutic product, tested in mouse models, shows promise in addressing common pathways of lung disease progression.

Research from the centers will help drive new knowledge and foster positive and lasting societal benefits.

For 11 consecutive years, U.S. News has named UAB Hospital the best hospital in Alabama, with several specialties and procedures ranked among the best.

Whitfield’s eight-bed ICU is monitored remotely 24/7 by the UAB Tele-ICU team to help support the bedside staff.

The study will observe two sedation medications, ketamine and etomidate, that are most commonly used for sedations, ketamine and etomidate, to determine which is best during intubations.

Chronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements after treatment with the monoclonal antibody dupilumab.

UAB experts says that individuals can prevent or decrease symptoms of sleep apnea by making small lifestyle changes.

Cigarette smoking is associated with COPD, and each cigarette has 2 to 3 micrograms of cadmium.

Vivek Lal, M.D., associate professor in the Department of Pediatrics at UAB Heersink School of Medicine and the founder of both ResBiotic Nutrition and Alveolus Bio, was given the 2023 Award for Excellence in Entrepreneurship.

The Blazer Bridge Fund is intended to identify and assist in the development of promising ideas, discoveries, innovations and/or technologies from UAB faculty and staff that have commercial potential. 

Chronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements in their disease after treatment with the monoclonal antibody dupilumab.

Description of this mechanism offers a promising therapeutic target to limit lung injury and death. Lower respiratory tract infections, including bacterial pneumonia, are the fourth-leading cause of death worldwide, with 120 million to 156 million cases and 1.4 million deaths a year.

Having a bacterial infection at the same time as COVID-19 is a greater risk factor for COVID-19 severity and mortality than previously described risk factors such as advanced age, male sex or various comorbidities.

Sarcoidosis is an inflammatory disease characterized by the formation of granulomas in one or more organs of the body.